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Abstract. Laminin is the first extracellular matrix
protein expressed in the developing mouse embryo. It
is known to influence morphogenesis and affect cell
migration and polarization. Several laminin receptors
are included in the integrin family of extracellular ma-
trix receptors. Ligand binding by integrin heterodimers
results in signal transduction events controlling cell
motility. We report that the major laminin receptor on
murine embryonic stem (ES) cells is the integrin het-
erodimer a601, an important receptor for laminin in
neurons, lymphocytes, macrophages, fibroblasts, plate-
lets and other cell types. However, the cytoplasmic do-
main of the ES cell a6 («6B) differs totally from the
reported cytoplasmic domain amino acid sequence of
a6 (a6A) . Comparisons of a6 cDNAs from ES cells and
other cells suggest that the a6,, and a6B cytoplasmic
domains derive from alternative mRNA splicing.
Anti-peptide antibodies to a6, are unreactive with ES
cells, but react with mouse melanoma cells and em-
N mammalian embryonic development, morphogenic
events are governed by several primary cellular pro-
cesses including cell-cell and cell-substratum interac
tions, direction-specific migrations, and regulated prolif-
erative events. These phenomena may be influenced by the
extracellular matrix (ECM)1 components in the immediate
environment of the pluripotent embryonic cells (Ekblom et
al., 1986; Edelman, 1988; Thiery, 1989).
A specialized ECM, the basement membrane, is the first
ECM to appear during mammalian embryogenesis (Martin
and Timpl, 1987). The major component of all basement
membranes, laminin (Ln), is comprised of three large poly-
peptides (A, BI, and B2), and appears to influence cell be-
havior in a variety of ways (Ekblom et al., 1986; Martin and
Timpl, 1987). To date, Ln has been shown to mediate cell
adhesion, spreading and migration, proliferation, neurite
outgrowth, and may also be effective in stimulating cellular
differentiation (Edgar et al., 1984; Aumailley et al., 1987;
1. Abbreviations used in this paper: ECM, extracellular matrix ; ES, embry-
onic stem; FN, fibronectin; LIF, leukemia inhibitory factor; Ln, laminin;
PCR, polymerase chain reaction; RTPCR, reverse transcription-polymer-
ase chain reaction; Vn, vitronectin.
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bryonic fibroblasts. When ES cells are cultured under
conditions that permit their differentiation, they be-
come positive for a6A, concurrent with the morphologic
appearance of differentiated cell types. Thus, expres-
sion of the «6Bß1 laminin receptor may be favored in
undifferentiated, totipotent cells, while the expression
of «6Aß1 receptor occurs in committed lineages. While
the functions of integrin a chain cytoplasmic domains
are not understood, it is possible that they contribute
to transferring signals to the eell interior, e.g ., by de-
livering cytoskeleton organizing signals in response to
integrin engagement with extracellular matrix ligands.
It is therefore reasonable to propose that the cellular
responses to laminin may vary, according to what a
subunit isoform (a6A or Q16B) is expressed as part of the
01601 laminin receptor. The switch from a'6B to a6A, if
confirmed in early embryos, could then be of striking
potential relevance to the developmental role of laminin.
Martin and Timpl, 1987; Kleinet al., 1988 ; Goodman et al.,
1989; Panayotou et al., 1989; Vukicevic et al., 1990). Ln is
the first ECM component to be expressed in the developing
mammalian embryo and is expressed widely throughout the
embryonic tissues thereafter (Cooper and MacQueen, 1983;
Ekblom et al., 1986) . It is markedly enriched in regions of
the embryo where epithelialhistogenesis is occurring and is
believed to be responsible for initiating and maintaining the
polarized state of epithelial cells (Klein et al., 1988; Sorokin
et al., 1990). It has been demonstrated that Ln is directly in-
volved in the conversionof mesenchyme to epithelium in the
developing murine kidney. Initially it was observed that Ln
B chains were constitutively expressed in kidney mesen-
chyme while A chain expression was coincident with the on-
set of cell polarization as the cellsconverted to an epithelial
phenotype (Klein et al., 1988). Moreover, addition of anti-
bodies, specific for the distal end of the long arm of Ln (the
E8 fragment), was found to inhibit the polarization of de-
veloping epithelialcellsduring conversion in embryonic kid-
ney organcultures (Klein et al ., 1988). Thus, it appears that
Ln is essential for epithelial development during kidney em-
bryogenesis and that the timing of this event is orchestrated
by the onset of Ln A chain synthesis .
843Over recent years a large family of cell surface receptors
for many ECM components have been identified and termed
integrins (Hynes, 1987; Ruoslahti, 1988 ; Albelda,and Buck,
1990 ; Hemler, 1990 ; Springer, 1990) . These receptors
mediate cell adhesion and migration in a specific fashion via
selected interactions with ECM components . Evidence is
now accumulating that engagement of ligand by the integrin
heterodimers results in signal transduction events leading to
cell motility, proliferation, or activation (Hemler, 1990 ;
Springer, 1990) . Although there are severalmembers of the
integrin family that have been characterized asLn receptors
(01101, 001, a3ß,, and a6ß,), most have been shown to have
multiple specificities for other ECM components (Hemler,
1990) . However, the a6ß, integrin is specific only for Ln
(Sonnenberg et al., 1988) . Furthermore, the binding site of
a6ß1 on Ln has been identified and is located within the E8
proteolytic fragment derived from the long arm of the Ln
molecule (Hall et al., 1990 ; Sonnenberg et al ., 1990) . Re-
cent evidence now suggests that the a6ß, integrin may play
a key role in mediating the effects ofLn during embryogene-
sis . Using the murine embryonic kidney mesenchyme/epi-
thelial conversion model described above, Sorokin et al .
(1990) demonstrated that expression of the C16 subunit and
the Ln A chain was coordinately regulated at the point in de-
velopment at which the nonpolarized mesenchymal cells
were converting to polarized epithelial cells . In addition, in
organ cultures, a monoclonal antibody specific for the 016
subunit also inhibited epithelial development (Sorokin et al .,
1990) . Therefore, the 01601 integrin plays an integral role in
the induction of polarity during the differentiation of em-
bryonic kidney mesenchyme into epithelium . Since Ln is ex-
pressed widely throughout the embryo, a general role may
be hypothesized for Ln and its receptor, a6ß,, in many of
the morphological events leading to the development of cell
polarity during embryogenesis .
Thus, it is likely that Ln, and therefore a6ß1, are also
directly involved in the events of preimplantation develop-
ment . As was observed for the developing kidney epithe-
lium, the Ln A, Bl and B2 chains are noncoordinately ex-
pressed . While both the Bl and B2 chains can be detected
by immunohistochemistry at the 4-cell stage, the A chain
polypeptide is not detected until the 8- to 16-cell stage after
compaction has begun (Cooper and MacQueen, 1983) .
Mouse embryonic stem cells (ES cells) are continuous cell
lines that outgrow from the inner cell mass of cultured
preimplantation mouse embryos, and that maintain the
potential to support normal development of embryonic and
extraembryonic structures when reinjected into blastocysts
and implanted (Robertson et al ., 1986) . Here we demon-
strate that the integrin, a6,ß,, is the major Ln receptor on
ES cells . We further show that the 016 subunit of this recep-
tor is expressed inES cells as an isoform with a cytoplasmic
domain structurally distinct from that previously described
for a b . In addition, in vitro differentiation of the pluripotent
ES cells is accompanied by the induction of expression of
016 chains with the conventional cytoplasmic domain .
Materials andMethods
Cell Lines
The ES cell line, CCE (Schwartzberg et al ., 1989) was initially cultured
on murine embryonic fibroblasts (STO cells) to prevent differentiation . To
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study the expression and function of integrins in this ES cell line it was
necessary to remove the STO cells from the culture system . Therefore, the
CCE ES cell line was subcloned into leukemia inhibitory factor (LIF) (103
units/ml) (Amrad Co., Victoria, Australia) containing media (DMEM;
10% FCS, 100 pM 0-mercaptoethanol, 2 mM glutamine) . LIF has been
shown to prevent ES cell differentiation (Moreau et al ., 1988; Smith et al .,
1988 ; Williams et al ., 1988) . The sublines were cultured on gelatin (0.1%)
coated plates . Several subclones were expandedand continually cultured in
LIFcontainingmedia. The sublineESl was chosen for the studies described
here . The D3 embryonic stem cell line was derived by Doetschman et al .
(1985) . D3 cells were cultured in LIF containing medium as described
above except that 15% FCS was used . ESl and D3 cells were allowed to
differentiate on gelatin (0.1%) coated plates over a period of 8-9 d in the
absence of LIF.
The murine B16F1 melanoma line was derived from a C57B1/6 mela-
noma and cultured in DMEM, 5% FCS, 2 mM glutamine and penicillin-
streptomycin (50 IU/ml-50 pg/ml) .
Antibodies andExtracellular Matrix Components
The rabbit polyclonal anti-NA cytoplasmic domain antiserum (6844) was
raised against the last 15 amino acids (IHAQPSDKERLTSDA) of the
reported human a6 sequence (Tatnura et al ., 1990), while the 382 antisera
was raised to a synthetic peptide from the carboxy terminus of human a6e
(KDEKYIDNLEKKQWITKWNRNESYS) (Tamura et al ., 1991) . An addi-
tional cysteine residue was included at the NHZ terminus for coupling pep-
tides to a protein carrier (keyhole lympet hemocyanin) for immunization.
Therat monoclonal antibody, GoH3, is specific for an extracellular epitope
on both the human and murine 016 subunit (Sonnenberg et al ., 1987) . The
isotype matched control antibody, B3B4, recognizes the B lymphocyte
specific antigen, CD23. The anti- 016 specific monoclonal antibody, 135.13c,
and the control antibody, 439.9b, specific for the human 04 integrin sub-
unit, have been described (Kennel et al ., 1989) . Anti-peptide antisera to
the cytoplasmic domains of rat 011, chicken as, human 014, human 015, and
human 01 sequences were shown to be cross-reactive with the respective
mouse 01 integrins by immunoprecipitation of B16F1 melanoma, STO
fibroblast, and MMT carcinoma murine cell lines.
Humanfibronectin (Fn), human vitronectin (Vn) and humantype IV col-
lagen (Col IV) were purchased from Telios (La Jolla, CA) . Murine laminin
(Ln) and the basement membrane preparation, Matrigel, were obtained
from Collaborative Research, Inc ., Waltham, MA .
CellAdhesion Assays
Cell adhesion assays were carried out as follows . Wells of 96-well plates
(Linbro/Titertek ; Flow Laboratories, Inc., McLean, VA) were coated with
a variety ofextracellular matrix components at a concentration of 1 X 10- s
M over a period of 16-18 h at 4°C. The wells were then washed twice with
Dulbeccds PBS containing Mg" and Cal' (DPBS) (Flow Laboratories,
Inc .) and blocked for 30 min with 0.1% BSA in DPBS. After a final wash
with DPBS, 2 X 105 cells were added per well and incubated for the given
period of time at 37°C. Cells were added to the wells in 100 pl ofDMEM
containing 1% FCS, 103 units/ml of LIF, 100 ttM 0-mercaptoethanol,
2 mM glutamine, penicillin-streptomycin (50IU/ml-50 lig/mil), and 80 fig/
tnl gentamicin . In the case of antibody inhibition assays, 1 X 105 cells (50
pl per well ;DMEM, 2% FCS, 2 X 103 units/ml LIF, 200pM 0-mercapto-
ethanol, 4mM glutamine, penicillin-streptomycin (100 IU/ml-100 ug/ml),
160 gg/ml gentamicin) were plated per well and incubated for 8 h at 37°C
inthe presence ofthediluted antibody supernatants (50 /allwell) . Nonadher-
ent cells were removed from wells by washing twice with DPBS. Adherent
cells were fixed for 5 min in 3 % paraformaldehyde, 2 % sucrose at room
temperature. Adherent cells were stained with 0.5% crystal violet in 20%
methanol . The plates were then dried, the stain solubilized in 0.1 M citric
acid in 50% ethanol (pH 4.2) and theOD at 550 nm determined using an
EIA Elisa reader (BioTek Instruments, Inc., Burlington, VT) . Nonspecific
adherence was determined by plating cells on BSA coated wells for the ap-
propriate period oftime . Specific adhesion to a given substrate was calcu-
lated by subtracting OD (550 nm) obtained with cells plated on BSA from
that observed for cells plated on specific substrate . For adhesion inhibition
assays with antibodies, results are expressed as "% Maximum Adhesion,"
where maximum adhesion represents the OD(550 mn) ofcells plated in the
absence of any antibody, minus nonspecific adhesion on BSA .
Cell LabelingandImmunoprecipitations
Undifferentiated ES cells (1-2 X 101 cells) were surface labeled with
844Na125I using the lactoperoxidase procedure (Roth, 1975). Differentiated
ES cells proved to be significantly more fragile than undifferentiated ES
cells and did not survive the more rigorous washing steps required during
the iodination procedure. Therefore, differentiated ES cells were metaboli-
cally labeled with [35S]methionine as described previously (Kajiji et al.,
1989). Preparationofnonionic detergent cell lysates, immunoprecipitations
and analysis by SDS-PAGE were performed as described by Kajiji et al.
(1989).
Flow Cytometry
ESl cells were detached using 10 mM EDTA while in log phase of growth.
1 x 106 cells were stained with a 1:100 dilution of ascites from the a6
specific monoclonal antibody, 135.13c, or the isotype-matched control anti-
body, 439.9b, for 30 min at4°C. Afterwashing three times with DPBS, cells
were incubated in the presence of the secondary anti-rat IgG antibody la-
beled with fluorescein isothiocyanate (Boehringer Mannheim Biochemi-
cals, Indianapolis, IN) (30 min, 4°C). Cells were then washed three times
with DPBS and fixed with 0.1% paraformaldehyde in DPBS beforeanalysis.
Cells were analyzed on a FRCS® 440 (a registered trademark of Becton
Dickinson and Company for a fluorescence-activated cell sorter) .
Cloning ofU6cDNA FragmentsbyPolymerase Chain
Reaction (PCR)and cDNA Sequencing
Poly(A)' RNA was isolated from both differentiated and undifferentiated
cell lines using the Invitrogen Fastrack Kit (Invitrogen, La Jolla, CA) .
Single-stranded cDNA was then synthesized from 10 pg of mRNA using
AMV reverse transcriptase (20 U; Molecular Genetics Resources, Tampa,
FL) and 1 Agof random hexamerprimers (Pharmacia Inc., Piscataway, NJ).
The cDNAs were then ethanol precipitated and resuspended in 50-70 Al of
water. 1 pl of cDNA was amplified per 50 Al PCR reaction mixture (2.5
MM M9C12, 50 mM KCI, 10 mM ß-mercaptoethanol, 66 mM Tris-HCI,
pH 8.3) using 0.1 AM oligonucleotide primers, 0.25 mM each of dATP,
dTTP, dCTP, and dGTP, and 1.25 U of Taq 1 polymerase (AmpliTaq;
Perkin-Elmer Corp., Cetus, CA). The PCRprogramconsisted of two steps.
(a) 40 cycles of 1 min at 94°C, 2 min at 55°C, and 3 min at 72°C with a
5 s/cycle extension on the 72°C segment; (b) 10 min at 72°C and a final
shift to 4°C. Nested pairs of PCR primers were used to ensure that a6
specific fragments were amplified. Both sets were derived from the human
cDNA sequence as determined by Tamura et al. (1990). The first set cor-
responded to basepairs 2,918-2,937 (primer 1,157) and 3,454-3,473 (pri-
mer 1,156) of the human a6 sequence while the nested primer pair corre-
sponded to basepairs 2,942-2,960 (primer 1,681) and 3,433-3,452 (primer
2,002). Second round PCR was carried out on 1 Al of the reaction mixture
generated from the first round PCR.
Amplified a6An and a6B fragments from first round PCR (primer pair
1,156/1,157) were purified using GeneClean (Bio 101, La Jolla, CA), treated
with DNA polymerase I and T4 polynucleotide kinase, again purified with
Gene Clean, and subcloned into Bluescript-pKS+ (Stratagene, La Jolla,
CA). Positive clones were sequenced manually (Sequencee kit; U.S. Bio-
chemical Corp., Cleveland, OH) using T3 and T7 polymerase vector
primer sequences. Sequences were analyzed on a VAXVMS, version 5.2
computer, with programs of the University of Wisconsin Genetics Com-
puter Group (Devereux et al., 1984) .
Results
TheMajorLaminin Receptor ofESCellsIs
the a6ß,Integrin
A variety of embryonic stem cell lines (ES cells) have been
described (Baribault and Kemler, 1989) and proposed as
model systems with which to study morphogenesis in early
development (Doetschman et al., 1985 ; Rossant, 1990).
Therefore, to explore the role of a6ß, in preimplantation
mouse embryos, we have examined the expression and func-
tion of this Ln receptor in ES cells.
Initially, the adhesive phenotype of the ESl cell line was
determined. Cell adhesion assays were carried out in 96-well
tissue culture plates which had been coated with various
ECM components. ESl cells (2 x 105 cells/well) were in-
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cubated for the indicated time and the number of adherent
cells quantitated by staining with crystal violet after fixing
with paraformaldehyde. ESl cells displayed strong avidity
for Ln, Fn, and Matrigel (a basement membrane extract con-
taining Ln, Fn, collagen IV, and proteoglycans) after2 h and
maintained this level of adhesion over the full 24-h incuba-
tion period (Fig. 1) . In contrast, no adhesion to vitronectin
or type IV collagen was observed.
To determine whether the ES1 cells expressed the integrin
Ln receptor, a6ß,, immunoprecipitations were carried out
on detergent lysates from ESl cells surface labeled with
1251, Autoradiographs of 5 % SDS-PAGE gels revealed that
the ci6 subunit-specific monoclonal antibodies GOH3 (Fig.
2) and 135.13c (not shown) precipitated two proteins of 130
and 150 kD under non-reducing conditions. The mobilities
ofthese protein bands corresponded to those expected for the
integrin ß, and a6 subunits, respectively, indicating that the
a6ß1 heterodimer was present at the cell surface.
Fluorescence-activated flow cytometry demonstrated that
the 135.13c monoclonal antibody brightly stained a single
homogeneous populationof ES1 cells(Fig. 3) . Thus, the ES1
cell line is comprised of a single homogeneous population
of a6ß, positive cells.
Immunoprecipitations of I'll surface-labeled ESl cell ly-
sates with antisera to peptides corresponding to the cyto-
plasmic domains of the integrin subunits ci l, CO, 014, a5, and
ß, revealed that ES1 cells also expressed the a5ß, and a3ß1
integrins on their surface (data not shown) . No other ßl
integrins were detectable in these immunoprecipitation ex-
periments (note, however, that no anti-mouse 012 antibodies
were available). The integrin, a5ß1 , has been shown to be
specific for Fn only (Ruoslahti, 1988), while a,ß1 has been
demonstrated to have multiple specificities for Fn, Ln, and
collagen (Elices et al., 1991). Therefore, the specificity pat-
tern of ESl cell adhesion observed in Fig. 1 correlated well
with the expression of a6ß1, a3ß,, and a5ß1 .
Cell adhesion assays were carried out in the presence of
the monoclonal antibody, GoH3, which is specific for the
a6 subunit. Fig. 4 demonstrates that GoH3 culture superna-
tant, at a dilution of 1:50, inhibited ESl cell adhesion to Ln
by >95 % compared to control. In contrast, at the same con-
centration, GoH3 inhibited ESl cell adhesion to Fn by
<20% ofcontrol. The control was the isotype-matched anti-
body B3B4, which had little or no effect on ESl cell adhesion
to either Ln or Fn, compared to wells with no antibody.
Specific inhibition of Ln adhesion by GoH3 was reproduc-
ibly observed in five independent assays, indicating that
a6ß 1 is the major integrin, if not the only one, used as a Ln
receptor by ESl cells. This would imply that the a3ß1 inte-
grin does not function as a Ln receptor on these cells, at least
in our culture and/or assay system.
EmbryonicStem Cells Express aStructurally Di fferent
Formofthe a6Integrin
Immunoprecipitations of 1251-labeled ESl lysates revealed
that a polyclonal rabbit antiserum (6844), raised against the
last 15 amino acid residues of the human a6 subunit, did
not precipitate the a6ß, heterodimer from ESl cell lysates
(Fig. 2). However, this antiserum did precipitate a6ß1 from
1251-labeled lysates of a murine melanoma line (B16F1) (Fig.
2) indicating that this antiserum did cross-react with the mu-
rine a6 subunit. In addition, the polyclonal anti-cytoplas-
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mit domain antiserum also precipitated the a6 subunit from
both a murine embryonic fibroblast line (STO) and a murine
mammary tumor cell line (MMT) (data not shown) . Im-
munoprecipitations were also performed on 'III-labeled ly-
sates from the D3 ES cell line (Doetschman et al., 1985) .
As was observed for ESI lysates, theGoH3 monoclonal anti-
body, but not the 6844 polyclonal antiserum, immunopre-
cipitated the a6ß, heterodimer (not shown) . Therefore, the
016 subunit expressed by ES cells lacked the epitope within
the a6 cytoplasmic domain that is recognized by the 6844
antiserum .
To investigate possible structural differences within the cy-
toplasmic domain of the 016 subunits expressed by ESI and
B16F1 cells, amplification ofa6 cDNA by reverse transcrip-
tion-polymerase chain reaction (RTPCR) was carried out
Figure 2 . Immunoprecipitations of a6ß, from "Mabeled deter-
gent lysates oftheembryonic stem cell lines ESI (A) andthe murine
melanoma line, B16FI (B) using the monoclonal antibody GoH3,
specific for an epitope on the extracellular domain of u6 or the
polyclonal antisera, 6844, specific for the cytoplasmic domain of
um and 382, specific for the cytoplasmic domain of «6B . Im-
munoprecipitations were analyzed by 5% SDS-PAGE under non-
reducing conditions . The upper band (-150,000 D) corresponds to
u6, the lower band (-130,000 D) corresponds to ßl . Molecular
mass markers on the right are in daltons .
on mRNA from these cells . A nested set of PCR primers
(primer pairs 1,157/1,156 and 1,681/2,002), derived from the
human 016 sequence (Tamura et al ., 1990), were used to en-
sure specificity ofthe reaction . Fig . 5 a shows the PCR prod-
ucts obtained . The RTPCR fragment amplified from B16F1
melanoma mRNA corresponded to the size expected (510
bp) for the murine homologue of the human 016 (Fig . 5 a,
lane 2) . However, the PCR fragment obtained from the am-
plification ofthe ESI cellcDNA was smaller (-380 bp) . Ad-
ditional amplifications from four independent ESI mRNA
preparations yielded only the 380-bp fragment and never the
larger fragment amplified from B16F1 melanoma .
TheRTPCR fragments from the ESI and BI 6171 cells were
subcloned and sequenced . The sequence of the larger B16F1
fragment (Fig . 6) was 89% identical to the human 04 se-
quence (Tamura et al ., 1990) at the nucleotide level and 91
identical at the amino acid level, indicating that it likely
represents the murine homologue of the a6 subunit . The
B16F1 RT-PCR fragment (Fig . 6) encoded the carboxy-
terminal portion of the extracellular domain as well as the
transmembrane and cytoplasmic domains of the a6 subunit.
The sequence of the smaller RTPCR fragment (Fig. 6)
was identical to the B16F1 sequence except that an internal
deletion of 130 by was observed . Tamura et al . (1991) have
recently described a second form of the human a6 subunit
mRNA (a 6B) in which the segment encoding the cytoplas-
mic domain of the published sequence (a6A) was absent . In-
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Figure 1. Time course of ESI cell
adhesion to extracellular matrix
components. Cells were incubated
inwells coatedwithlaminin (I-N),
fibronectin (Fn), Matrigel (MG),
vitronectin (Gn), or type IV colla-
gen (Coll IV) for the indicated
length oftime . Adherentcells were
fixed and then quantitated by stain-
ing with crystal violet followed by
solubilizationanddeterminationof
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the optical density at 550 run in an
automated ELISA reader.
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Figure 3. Fluorescence-activated flow cytometry of ESI cells labeled
with (a) the isotype-matched control monoclonal antibody, 439.9b,
or (b) the u6 subunit-specific monoclonal antibody, 135.13c .Figure 4 . Inhibition of ESI cell
adhesion to laminin. ESI cells
were incubated in laminin- or fi-
bronectin-coated wells in thepres-
ence of the anti-a6 monoclonal
antibody, GoH3, or the isotype-
matched antibody, B3B4 . After
8 h incubation, cells were fixed,
stained, solubilized, and quanti-
tatedby determining optical den-
sity at 550 nm . Results are ex-
pressedas percentage ofmaximum
adhesion,whichis represented by
wells in which no antibody was
added . Antibodies were used as
1:50 dilutionofhybridoma supernatant(-0.2 /.glml) . Control anti-
body was the rat monoclonal B3B4 .
stead, a reading frame from the 3' untranslated region of the
a6Asequence encoded a novel cytoplasmicdomain . The hu-
man a6BcDNA was found to be 130by shorter than the a6A
isoform. Thelocation of the 130-bp deletion observed in the
ESI a6 PCR fragment exactly matched that of the human
a6B sequence. Therefore, it appeared that ESl cells could
express the murine equivalent of the a6B isoform . To verify
this possibility, immunoprecipitations were carriedout with
an antiserum (382) raised against a synthetic peptide corre-
sponding to the sequence of the cytoplasmic tail ofhuman
a6 .
Fig.2 shows that antiserum382precipitated proteinbands
virtually identical to those reactive with anti-ae monoclo-
nal GOH3, indicating that ESI cells do express a6B protein,
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Figure 6 . Nucleotide sequence of the a6 fragments (see Fig. 5)
amplifiedbyRTPCRfrom ESl (top line) and Bl6F1 (bottom line) .
Thearrows indicate thepositionofthe 1,157 and 1,156 primers . The
numbers at the right correspond to the published human a6 se-
quence (Tamura et al ., l9ß0). The gap in the ESl a6B sequence
(top line) is marked with a dotted line. Translation is shown under
the nucleotide sequences, in the one letter amino acid code . The
asterisk indicates a stop codon . The sequence GFFKR, which is
conserved in all integrinachain cytoplasmic domains, is in shaded
boxes .
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RTPCR amplification of (A) ES1 and B16Fï mRNAs and (B) undifferentiated and differentiated ES1 MRNÁS using the a6
specific primer pairs 115711156 (see Fig. 6 for position of these primers in the a6 sequence), and the nested primer set 168112002. The
upper band (-510 bp) derives from cYfiA mRNA, the lower band (-380 bp) derives from a6B mRNA . See text for further explanations .
Size of migration standards (outer lanes) is indicated in basepairs .probably complexed with ß, . Similar results were obtained
with another ES cell line, D3 (not shown) . Note that antise-
rum 382 is unreactive with the melanoma cell line B16F1,
which expresses instead the a6A isoform (Figs . 2 and 5) .
Conversely, anti-a6A rabbit antiserum 6844 is negative with
ESl cells and positive with B16F1 .
Bands immunoprecipitated by 382 antiserum are much
weaker than those precipitated by GOH3 (Fig . 2) . This, how-
ever, is probably due to low affinity of 382 for mouse a6B .
Depleting ESl lysates by four rounds of immunoprecipita-
tions with 382 almost completely removed reactivity of
GOH3, while depleting the lysates with normal rabbit serum
had no effect (not shown) . It is therefore unlikely that other
forms of a6 (i.e., carrying the GOH3 but not the 382 epi-
tope) are expressed in ES1 cells, although better reagents are
necessary to rule out this possibility formally.
TheExpression ofthea6A Isoforrn Is Initiated upon
Di fferentiation ofPluripotent Cells
To determine whether the expression of a6A could be initi-
ated upon differentiation, ES1 cells were allowed to differen-
tiate over a period of 8-9 d in the absence ofLIR The mor-
phology of the differentiated cells was dramatically different
from that of undifferentiated ESl cells maintained in LIF.
Primary and nestedPCRs were then carried out as described
above . As expected, PCRs on cDNA from undifferentiated
ES1 cells, using a6 specific primers, produced the 380-bp
fragment corresponding to the C16B cytoplasmic sequence
(Fig . 5 b, lane 1) . However, similar amplification ofcDNA
from the differentiated cells produced two distinct fragments
of 510 and 380 by (Fig . 5 b, lane 2) shown by nucleotide se-
quencing to be the UM and a6B isoforms, respectively .
Moreover, Fig . 7 a demonstrates that, in contrast to the
immunoprecipitation data from undifferentiated ES1 cells
(Fig . 2), the anti-cytoplasmic domain polyclonal antiserum,
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Figure 7 . Immunoprecipitations
of u6j, and a613ß, from 35S-la-
beled detergent lysates of differ-
entiated embryonic stem cell lines
ESl (A) and D3 (B) using the
monoclonal antibody, GoH3, spe-
cific for 016, and the polyclonal
antiserum, 6844, specific for the
cytoplasmic domain of a6A . Im-
munoprecipitations were analyzed
by 5% SDS-PAGE under nonre-
ducing conditions . The upperband
(-150,000D) corresponds to «6,
whilethelower band (-130,000D)
corresponds to ß, . Note that in
ESl cells an immature form of
ß, (-105,000D) preferentially in-
corporates [35S]methionine under
theradiolabelingconditions used .
The position of mature ß, is indi-
cated by black dots . For unknown
reasons, immature 0, was con-
sistently found inGOH3, but not
6844 immunoprecipitates, while
mature ß, is present in immuno-
precipitations with either antibod-
ies . Molecular mass markers on
the right are in daltons.
6844, could immunoprecipitate the aiba, isoform from [35S]-
methionine-labeled lysates obtained from differentiated ESl
cells or D3 cells. Thus, differentiation ofES cells is accom-
panied by the induction of expression of the a6A isoform .
In this paper we show that the major, if not the only, laminin
receptor expressed by mouse ES cells is a member of the
integrin family, a6ß, . Furthermore, we show that mouse a6
can exist in two versions, a6B and a6A, which contain struc-
turally distinct cytoplasmic domains . ES cells express exclu-
sively a613ß, in the undifferentiated, pluripotent state . Upon
differentiation, they begin expressing also the NA isoform
of a6 .
Murine embryonic stem cells have proven to be a valuable
model for studying biochemical and morphological events
occurring in early mammalian development . These cells
closely resemble the pluripotent cells within the inner cell
mass of the blastocyst from which they are derived . More-
over, in vitro differentiation of ES cells parallels the normal
developmental events which give rise to all embryonic tis-
sues (Evans and Kaufman, 1981 ; Doetschman et al ., 1985) .
Furthermore, when these cells are injected into blastocysts,
they are capable of contributing to 80-90% of the cells in
the resulting chimeric animal, including the germline (Rob-
ertson et al ., 1986 ; Baribault and Kemler, 1989) . Therefore,
ES cells provide a useful model for studyingcell-ECM inter-
actions mediated by integrins during early embryogenesis .
The data presented here indicate that integrins are ex-
pressed and used by ES cells. In comparison to most cell
lines, the ES1 cell line expressed a limited repertoire of
ß, integrins . Immunoprecipitations of radiolabeled lysates
from ESl cells demonstrated that they express significant
levels of the a6ß, Ln receptor on the cell surface (Figs . 2and 3). They also express the Fn receptor, a5ß,, and the
multi-specific integrin, COB, (Ln, Fn, and collagen). The
expression of integrin Ln and Fn receptors on ES cells is in
accordance with immunocytochemical data which shows
that by the 8-cell-stage of preimplantation development both
Ln and Fn are expressed at significant levels (Fleming and
Johnson, 1988; Kimber, 1990). Interestingly, the pluripotent
F9 teratocarcinoma line, also used as a model for early em-
bryonic development (Hogan et al ., 1981; Grover et al .,
1983) expresses the same ß, integrin repertoire of a6ß,,
a5ß,, and a3ß, (data not shown). While it is possible that
ES cells may express other as yet unidentified integrin het-
erodimers, their limited integrin repertoire agrees well with
theiradhesive phenotype. ESl cellsspecifically adhere to Ln
and Fn but not to vitronectin and type IV collagen (Fig. 1).
We have demonstrated that the a6ß, integrin is the major
Ln receptor on ESl cells (Fig. 4). This is also true for the
F9 teratocarcinoma (data not shown). It is likely that the
a5ß, integrin is the primary Fn receptor since in most cell
types bearing a5ß,, it is the predominant Fn receptor (Al-
belda and Buck, 1990; Hemler, 1990). In contrast, the ECM
adhesive activity of a3ß,, which is specific for Ln, Fn, and
collagen, has been shown to be weak in the presence of other
integrins with similar specificity (Elices et al ., 1991) . It is
possible that in ES cells a3ß, may be involved in cell-cell
interactions rather than cell-ECM interactions as has been
suggested for other cell types (Carter et al., 1990; Larjava
et al., 1990). Specific antibodies capable of inhibiting mu-
rine a3 and as function would be useful in addressing these
points. However, such reagents are currently unavailable.
Of major interest is the fact that a6ß, expressed by ES
cells possesses a novel a6 cytoplasmic domain that is struc-
turally distinct from that of the published a6 subunit (Tam-
ura et al., 1990). This conclusion is based on several lines
of evidence. First, although specific monoclonal antibodies
demonstrated that a6ß, was expressed at the cell surface
(Figs. 2 and 3), polyclonal antisera specific for the human
a6 cytoplasmic domain did not immunoprecipitate a6ß, in-
tegrins from ESl detergent lysates (Fig. 2). Secondly, the nu-
cleotide sequence of a6 cDNA fragments amplified by PCR
from ESl cells contained an internal deletion of 130 bp, as
compared to a6 sequences amplified from mouse melanoma
cells. The ESl a6 sequence was found to be equivalent to
the human a6B isoform recently described by Tamura et al.
(1991). Thirdly, an antiserum to the human a6B cytoplasmic
domain reacted with complexes resembling a6ß, from ESl
radiolabeled detergent lysates. Since the same observations
were repeated with another ES cell line, D3, it seems plausi-
ble to postulate that ES cells, and by inference the pluripo-
tent embryonic cells of the inner cell mass, express exclu-
sively the a6B isoform.
Our data with ES cells grown in the absence of LIF show
that, upon differentiation, the other isoform of a6, a6A, is
induced. This agrees with preliminary findings indicating
that many differentiated cell types express a6A. However,
the fact that ES cells express solely the a6B isoform suggests
that this isoform may have specialized functions suited to the
dynamics of the cells of the inner cell mass during preim-
plantation embryogenesis.
Based on their structures, it is likely that the a6B and a6A
mRNAs arise by alternative splicing of primary transcripts.
The ES cell expression data suggest that this alternative
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splicing event may be developmentally regulated. A prece-
dent in this regard is the integrin gene apse, in which an
exon encoding part of the extracellular domain is alterna-
tively spliced during fly development (Brown et al., 1989) .
The biological consequence of the existence of two a6
isoforms bearing distinct cytoplasmic domains is as yet un-
known. It has been demonstrated that integrins provide a
physical link between the ECM and the cytoskeletal network
of the cell through interactions with talinand a-actinin (Hor-
witz et al., 1986 ; Otey et al., 1990). Evidence is accumulat-
ing that integrin heterodimers also participate in signal trans-
duction events (Sinigaglia et al ., 1989; Werb et al ., 1989;
Matsuyama et al., 1990). Since the cytoplasmic domains of
a6A and a6B display no homology at the amino acid level it
is possible that they interact with distinct sets of cytoskeletal
components. Alternatively, or in addition to differential
cytoskeletal interactions, theirpotential for phosphorylation
may be different and therefore may potentiate distinct signal-
ling pathways, or differentially attenuate the same pathway.
It has been demonstrated that the a6 subunit can be phos-
phorylated upon stimulation with phorbol esters (Shaw et
al., 1990).
Evidence from several laboratories indicates that many
integrins, including a6ß,, exist in a low affinity state that
can be converted to a high affinity state in response to cell
activation events (Dustin and Springer, 1989; Adams and
Watt, 1990; Shimizu et al., 1990). Therefore, it is possible
that the a6Áß, and a6Bß, receptors differ in their affinity for
Ln, or alternatively, that their affinity for Ln can be differen-
tially modulated.
It is now evident that the interaction between Ln and its
integrin receptor, a6ß,, plays an integral role in primary
morphological transformations during embryogenesis. Soro-
kin and colleagues (Sorokin et al., 1990) have clearly dem-
onstrated that a6ß, is directly involved in the conversion of
embryonic kidney mesenchyme to epithelium by ensuring
that the mesenchymal cells undergo the initial process ofpo-
larization. Cells ofthe inner cell mass undergo many similar
morphological transformations before and during gastrula-
tion (Fleming and Johnson, 1988; Kimber, 1990). As a6Bß,
is present in cell lines derived from the cells of the inner cell
mass it is likely that this integrin may be involved in polariza-
tion events that occur during this time. Also, the first cellular
polarization process of embryogenesis occurs during com-
paction (Fleming and Johnson, 1988; Kimber, 1990), the
time at which the Ln A chain is first detected (Cooper and
MacQueen, 1983) . Thus, a6Bß, may also play a role in driv-
ing the formation of the blastocyst. Ongoing studies in our
laboratory are addressing these questions.
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